Puma Biotechnology Falls As It Posts Mediocre Breast Cancer Results By: TalkMarkets May 14, 2015 at 14:54 PM EDT Shares of Puma Biotechnology are trading down 19% after the company reported mediocre efficacy and safety problems with its drug Read More >>